Why Is Moderna $MRNA Stock Up +9.88% Today? (Find out why any stock moved today on Tickeron.) • Moderna $MRNA shares jumped 9.88% to $160.00, adding $14.38 from the prior session's close of $145.62. • The move extends a weeks-long re-rating driven by the Phase 3 melanoma cancer-vaccine success announced with Merck. • Analyst upgrades and price-target hikes continued to provide fresh fuel, with several Wall Street firms raising their outlooks sharply. • The rally reflects short covering and momentum rather than a new company disclosure on the day. • The broader biotech tape was modestly higher, meaning MRNA advanced on its own specific catalyst, not sector-wide strength. • Traders are now watching the detailed Phase 3 data and upcoming oncology conference as the next swing factors. $NVAX $BNTX $CRSP $REGN $IBRX $VKTX $RXRX
published
Why Is Moderna $MRNA Stock Up +9.88% Today? (Find out why any stock moved today on Tickeron.) • Moderna $MRNA shares jumped 9.88% to $160.00, adding $14.38 from the prior session's close of $145.62. • The move extends a weeks-long re-rating driven by the Phase
$MRNA$NVAX$BNTX$CRSP$REGN$IBRX$VKTX$RXRX
Latest documented BWB result
$META market result
Exit $META with $6.10 profit from the sold Puts
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.